Condition
Stage IIB-III NSCLC clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Stage IIB-III NSCLC clinical trials that are recruiting, at sites in 3 countries (most in China (3), France (2), Italy (2)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 3Countries
Newest Stage IIB-III NSCLC clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Robotic-assisted sleeve lobectomy after neoadjuvant chemoimmunotherapy for stage IIB-III non-small cell lung cancer | — | Fuzhou, Fujian and 9 other locations | Recruiting | Apr 21, 2026 |
| Tumor downstaging and robotic lung surgery after pre‑operative chemo‑immunotherapy for stage IIB–III NSCLC | — | Fuzhou, Fujian and 9 other locations | Recruiting | Apr 14, 2026 |
| Toripalimab plus chemotherapy as additional treatment after surgery for non-small cell lung cancer | Phase 2 | Guangzhou, Guangdong | Recruiting | Jun 26, 2025 |
All recruiting trials (3)
-
Robotic-assisted sleeve lobectomy after neoadjuvant chemoimmunotherapy for stage IIB-III non-small cell lung cancer
See how often robotic-assisted sleeve lobectomy after neoadjuvant chemoimmunotherapy succeeds and what makes the surgery harder for adults with stage IIB-III non-small cell lung cancer.
-
Tumor downstaging and robotic lung surgery after pre‑operative chemo‑immunotherapy for stage IIB–III NSCLC
This project will see if tumor and lymph node shrinkage after pre‑surgery chemo‑immunotherapy leads to safer operations and quicker recoveries for people with stage IIB–III non‑small cell lung cancer who have robotic lung surgery.
-
Toripalimab plus chemotherapy as additional treatment after surgery for non-small cell lung cancer
This tests whether adding toripalimab to cisplatin-based chemotherapy after complete surgical removal helps people with resected Stage IB–IIIB non-small cell lung cancer stay cancer-free longer.
Related topics
Quick answers
How many Stage IIB-III NSCLC clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), France (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.